General MedicationsORALGeneric
PERMAX
PERGOLIDE MESYLATE
Standard Dose
EQ 0.05MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview PERMAX is listed in Drugs@FDA under application 019385 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient PERGOLIDE MESYLATE Form and strength TABLET;ORAL - EQ 0.05MG BASE Sponsor VALEANT PHARM INTL Submission history Latest submission status date: 2003-10-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview PERMAX is listed in Drugs@FDA under application 019385 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PERGOLIDE MESYLATE Form and strength TABLET;ORAL - EQ 0.05MG BASE Sponsor VALEANT PHARM INTL Submission history Latest submission status date: 2003-10-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.